February 2016, Vol 6, No 2

On the Road to Compliance with USP 800: One Private Practice’s Journey

By Robert D. Orzechowski, MBA, SPHR, SHRM-SCP

Medical Professional Liability Claims Challenging for Physicians and Insurers

Midostaurin First Targeted Therapy to Improve Survival in Acute Myeloid Leukemia

By Phoebe Starr

ASH Issues 5 New “Choosing Wisely” Recommendations for Hematologists

Ibrutinib a New Standard of Care for Elderly Patients with Chronic Lymphocytic Leukemia

By Phoebe Starr

Medications Used for the Treatment of Kidney Cancers Associated with ICD-10 Codes

By Kristin A. Esposito, CPhT

ICD Codes, Cancer Drug Coding, Reimbursement

Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer

By Lisa A. Raedler, PhD, RPh

Congress Approves New Funding That Will Affect Cancer Care in 2016

Select Ongoing Trials Currently Enrolling Patients with Kidney Cancers

Clinical Trials Tracker

Liquid Biopsy Characterizing Circulating Tumor Cells Can Aid Treatment Selection

By Phoebe Starr

Prostate Cancer

Page 1 of 2

1
2